BRUGIA, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 868
EU - Europa 728
AS - Asia 215
Totale 1.811
Nazione #
US - Stati Uniti d'America 867
PL - Polonia 218
IT - Italia 186
IE - Irlanda 119
HK - Hong Kong 83
SE - Svezia 78
CN - Cina 49
JO - Giordania 41
AT - Austria 35
DE - Germania 23
CH - Svizzera 17
RU - Federazione Russa 16
SG - Singapore 16
IN - India 14
GB - Regno Unito 11
ES - Italia 8
VN - Vietnam 8
FI - Finlandia 5
TR - Turchia 4
UA - Ucraina 4
BE - Belgio 2
FR - Francia 2
NO - Norvegia 2
CA - Canada 1
NL - Olanda 1
PT - Portogallo 1
Totale 1.811
Città #
Warsaw 214
Chandler 123
Dublin 119
Fairfield 100
Ashburn 93
Hong Kong 56
Seattle 51
Cambridge 49
Houston 48
Woodbridge 45
Florence 38
Wilmington 36
Vienna 35
Altamura 32
Beijing 32
Lawrence 28
Ann Arbor 25
Bremen 20
Princeton 20
New York 18
Bern 17
Boston 15
Moscow 15
Buffalo 14
Medford 12
Pune 12
Singapore 11
Shanghai 10
Barcelona 8
Dong Ket 8
Milan 8
Rome 8
Kent 7
Boardman 6
Brescia 6
Falls Church 5
Amandola 4
Naples 4
San Diego 4
Alba 3
Ancona 3
Helsinki 3
London 3
Mykolayiv 3
Sesto Fiorentino 3
Andover 2
Argelato 2
Brusaporto 2
Brussels 2
Carmignano 2
Cinisello Balsamo 2
Dearborn 2
Frankfurt Am Main 2
Hangzhou 2
Hillsboro 2
Istanbul 2
Laurel 2
Mileto 2
Norwalk 2
Oslo 2
Padova 2
Palermo 2
Parma 2
Phoenix 2
Pisa 2
Radomsko 2
San Giovanni Valdarno 2
Shenzhen 2
Turin 2
Varese 2
Vico Equense 2
Washington 2
West Jordan 2
Aprilia 1
Baotou 1
Central District 1
Kilburn 1
Kunming 1
Lisbon 1
Los Angeles 1
Lucca 1
New Bedfont 1
Oggiono 1
Paceco 1
Paris 1
Petriolo 1
Philadelphia 1
Poggibonsi 1
Redmond 1
Sasso Marconi 1
Southend 1
Toronto 1
Trumbull 1
Valdobbiadene 1
Wandsworth 1
Totale 1.452
Nome #
Emerging drugs in refractory colorectal cancer 227
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 149
Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer. 104
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 101
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 99
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 85
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect 85
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 84
Regorafenib also can cause osteonecrosis of the jaw 80
Physical exercise and eating habits in cancer survivors 79
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 77
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 64
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 62
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 59
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 57
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 55
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 54
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 52
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study 42
Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy 37
Results of the observational prospective RealFLOT study 30
Current status and future perspectives in HER2 positive advanced gastric cancer 29
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 29
Somatostatin analogs in pregnant patients with neuroendocrine tumor 27
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO 23
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 20
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 17
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 15
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI 14
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 10
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 3
null 3
Totale 1.872
Categoria #
all - tutte 7.469
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.469


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201944 0 0 0 0 0 0 0 0 0 0 21 23
2019/2020281 20 13 9 15 32 29 35 31 27 26 37 7
2020/2021287 21 25 2 36 43 30 22 15 27 33 20 13
2021/2022138 4 7 5 3 2 10 1 20 11 13 16 46
2022/2023651 32 110 18 60 45 121 70 55 80 9 20 31
2023/2024352 9 25 37 18 20 64 26 81 8 34 30 0
Totale 1.872